CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Inverness Medical Techno. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Inverness Medical Techno.
51 Sawyer Road
Suite 200
Phone: (781) 647-3900p:781 647-3900 Waltham, MA  02453  United States Ticker: IMAIMA
This company was Merged or Acquired on 11/21/2001.
This company ceased filing statements with the SEC on 11/26/2001.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Inverness Medical Technology, Inc., formerly Selfcare, Inc., develops, manufactures and markets products focused primarily on diabetes self-management. The Company's principal products are advanced electrochemical blood glucose-monitoring systems that are used by people with diabetes to determine their blood glucose levels. Such systems utilize the Company's proprietary biosensor test strips, which quickly draw blood into the strip, require a small sample and provide users with the option of sampling from the forearm, thus avoiding the need for finger sticking. The Company also sells products for the women's health market and, to a lesser extent, the infectious disease market. Products for the women's health market include home pregnancy detection tests, ovulation prediction tests and a line of nutritional supplements. Products for the infectious disease market include tests used for the detection of certain diseases and agents, such as HIV-1 and HIV-2, hepatitis and chlamydia.
(Source: 10-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/200112/31/2000-Yes--Yes

Industries
SIC Code Description
3826 Laboratory analytical instruments

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President and Chief Executive Officer RonZwanziger 47 1/1/1992 1/1/1992
Executive Vice President, Secretary Kenneth D.Legg, Ph.D. 58 1/1/1999 11/1/1991
Vice President-Finance, Treasurer Duane L.James 41 10/1/2000 8/1/1998
8 additional Officers and Directors records available in full report.

General Information
Number of Employees: 871 (As of 12/31/2000)
Outstanding Shares: 32,629,243 (As of 11/9/2001)
Shareholders: 396
Stock Exchange: AMEX
Federal Tax Id: 043164127
Fax Number: (781) 647-3939


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023